208 related articles for article (PubMed ID: 24309928)
21. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
22. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
23. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
24. Triptolide induces protective autophagy through activation of the CaMKKβ-AMPK signaling pathway in prostate cancer cells.
Zhao F; Huang W; Zhang Z; Mao L; Han Y; Yan J; Lei M
Oncotarget; 2016 Feb; 7(5):5366-82. PubMed ID: 26734992
[TBL] [Abstract][Full Text] [Related]
25. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide.
Wang X; Matta R; Shen G; Nelin LD; Pei D; Liu Y
J Mol Med (Berl); 2006 May; 84(5):405-15. PubMed ID: 16385419
[TBL] [Abstract][Full Text] [Related]
27. Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells.
Qin W; Li S; Miao Y; Shi Q; Wang Y; Li J; Chen Z; Wang J; Ling C
Neoplasma; 2018; 65(1):21-33. PubMed ID: 29322785
[TBL] [Abstract][Full Text] [Related]
28. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
[TBL] [Abstract][Full Text] [Related]
29. Effect of triptolide on malignant peripheral nerve sheath tumours in vitro and in vivo.
Wang W; Lin W; Hong B; Li X; Zhang M; Zhang L; Lv G
J Int Med Res; 2012; 40(6):2284-94. PubMed ID: 23321185
[TBL] [Abstract][Full Text] [Related]
30. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
Miyata Y; Sato T; Ito A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
[TBL] [Abstract][Full Text] [Related]
31. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
33. Triptolide induces apoptosis in endometrial cancer via a p53‑independent mitochondrial pathway.
Wang XF; Zhao YB; Wu Q; Sun ZH; Li HJ
Mol Med Rep; 2014 Jan; 9(1):39-44. PubMed ID: 24213358
[TBL] [Abstract][Full Text] [Related]
34. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
Li CJ; Chu CY; Huang LH; Wang MH; Sheu LF; Yeh JI; Hsu HY
Cancer Lett; 2012 Jun; 319(2):203-213. PubMed ID: 22306340
[TBL] [Abstract][Full Text] [Related]
35. Dephosphorylation and mitochondrial translocation of cofilin sensitizes human leukemia cells to cerulenin-induced apoptosis via the ROCK1/Akt/JNK signaling pathway.
Zhang Y; Fu R; Liu Y; Li J; Zhang H; Hu X; Chen Y; Liu X; Li Y; Li P; Liu E; Gao N
Oncotarget; 2016 Apr; 7(15):20655-68. PubMed ID: 26967395
[TBL] [Abstract][Full Text] [Related]
36. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
Zhao X; Zhang Q; Chen L
Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934
[TBL] [Abstract][Full Text] [Related]
37. Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma.
Clawson KA; Borja-Cacho D; Antonoff MB; Saluja AK; Vickers SM
J Surg Res; 2010 Oct; 163(2):244-9. PubMed ID: 20691980
[TBL] [Abstract][Full Text] [Related]
38. Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways.
Zhou J; Xi C; Wang W; Fu X; Jinqiang L; Qiu Y; Jin J; Xu J; Huang Z
Toxicol Lett; 2014 Nov; 230(3):454-66. PubMed ID: 25169008
[TBL] [Abstract][Full Text] [Related]
39. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
40. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation.
Zhao F; Huang W; Ousman T; Zhang B; Han Y; Clotaire DZ; Wang C; Chang H; Luo H; Ren X; Lei M
PLoS One; 2013; 8(11):e80784. PubMed ID: 24244715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
